title: [Primary ileocecal lymphoma: report of 30 cases].
abstract: OBJECTIVE
  To investigate the best therapeutic method for primary ileocecal non-Hodgkin's lymphoma.
  
  
  METHODS
  Clinicopathologic features of 30 patients who had been treated from June 1964 to September 1993 were analyzed retrospectively.
  
  
  RESULTS
  Twenty-eight patients (93%) underwent resection of their disease. Eleven patients had the resection followed by chemotherapy. Eleven patients had the resection followed by chemotherapy and radiotherapy. All had pathologic evidence. Twenty-nine patients were categorized as B-cell type NHL. One had T-cell lesion. Eleven patients had stage I disease, 11 stage II, 4 stage III, and 4 stage IV. The 5-year survival rate was 36.67%.
  
  
  CONCLUSIONS
  The prognostic factors are stage of the disease and treatment modality. Adequate initial surgery combined with radiotherapy and chemotherapy may provide optimum therapy for patients with primary ileocecal lymphoma.
authors.affiliation: Abdominal Department, Tianjin Cancer Hospital, Tianjin 300060.
authors.forename: R
authors.initials: R
authors.lastname: Zhang
authors.forename: D
authors.initials: D
authors.lastname: Wang
authors.forename: X
authors.initials: X
authors.lastname: Huo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007078:Ileal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D007080:Ileocecal Valve / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D016019:Survival Analysis; D016896:Treatment Outcome